Company

💊 Novartis: Pioneering Global Healthcare Innovation​

HiSea-HH 2025. 4. 24. 23:40

Novartis AG, headquartered in Basel, Switzerland, is a leading multinational pharmaceutical company dedicated to reimagining medicine to improve and extend people's lives. With a rich history and a commitment to innovation, Novartis continues to shape the future of healthcare worldwide.​

🏛️ Company History

Established in 1996 through the merger of two Swiss companies, Ciba-Geigy and Sandoz, Novartis combined centuries of scientific expertise to form one of the world's largest pharmaceutical entities. The name "Novartis" is derived from the Latin "novae artes," meaning "new skills," reflecting the company's dedication to innovation. ​Novartis+3pharmaphorum+3Wikipedia+3Wikipedia

Over the years, Novartis has strategically focused on its core strengths in pharmaceuticals, divesting non-core businesses such as agribusiness and generics. Notably, in 2023, Novartis completed the spin-off of its generics division, Sandoz, to concentrate solely on innovative medicines. ​Wikipedia

💰 Revenue Model

Novartis generates revenue through the research, development, manufacturing, and marketing of prescription medicines across various therapeutic areas. The company's revenue streams include:​

  • Innovative Medicines: Sales from patented prescription drugs in areas such as oncology, cardiovascular, immunology, neuroscience, and ophthalmology.​
  • Strategic Collaborations and Licensing: Income from partnerships, co-developments, and licensing agreements.​
  • Other Revenues: Includes royalties, contract manufacturing, and other miscellaneous income.​

This diversified model ensures a stable and recurring revenue base, supported by a robust pipeline and global market presence.​Novartis

📊 Revenue Portfolio

In 2024, Novartis reported total sales of $53.8 billion, reflecting a 12% increase in constant currencies. ​Novartis

Top-selling products included:

These products significantly contributed to the company's robust financial performance. ​

🚀 Growth Strategy

Novartis's growth strategy focuses on:​

  • Innovation: Investing in cutting-edge research and development to bring novel therapies to market.​
  • Strategic Acquisitions: Expanding its portfolio through targeted acquisitions, such as the purchase of Anthos Therapeutics for up to $3.1 billion to enhance its cardiovascular offerings. Financial Times​
  • Digital Transformation: Leveraging digital technologies to improve drug discovery, development, and patient engagement.​
  • Global Expansion: Strengthening its presence in emerging markets to meet growing healthcare demands.​

These initiatives aim to drive sustainable growth and reinforce Novartis's position as a leader in the pharmaceutical industry.​

🌐 Official Website

For more information about Novartis's operations, history, and services, visit their official website: https://www.novartis.com